Bayesian Capital Management’s NOV NOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-21,100
Closed -$280K 396
2025
Q3
$280K Sell
21,100
-7,500
-26% -$96.9K 0.06% 394
2025
Q2
$355K Buy
+28,600
New +$360K 0.06% 355
2022
Q2
Sell
-18,700
Closed -$367K 982
2022
Q1
$367K Buy
+18,700
New +$327K 0.05% 466
2021
Q4
Sell
-23,200
Closed -$304K 473
2021
Q3
$304K Buy
+23,200
New +$313K 0.09% 263
2021
Q2
Sell
-10,217
Closed -$140K 572
2021
Q1
$140K Buy
+10,217
New +$148K 0.03% 481
2020
Q4
Sell
-56,300
Closed -$510K 606
2020
Q3
$510K Buy
56,300
+13,400
+31% +$157K 0.12% 221
2020
Q2
$526K Sell
42,900
-60,900
-59% -$748K 0.12% 232
2020
Q1
$1.02M Buy
+103,800
New +$1.96M 0.22% 128
2019
Q3
Sell
-23,000
Closed -$511K 630
2019
Q2
$511K Buy
+23,000
New +$556K 0.11% 260
2018
Q2
Sell
-8,400
Closed -$309K 675
2018
Q1
$309K Buy
+8,400
New +$308K 0.08% 388
2017
Q4
Sell
-9,051
Closed -$323K 664
2017
Q3
$323K Buy
+9,051
New +$296K 0.08% 348

Other funds holding NOV

Bayesian Capital Management's NOV Position: Q4 2025 in Review

Bayesian Capital Management sold out of NOV (NOV) in Q4 2025, closing a stake of 21,100 shares — an estimated $280K sold.

Bayesian Capital Management first reported a position in NOV in Q3 2017 and held it in 11 quarters. The position peaked at $1.02M in Q1 2020. 433 funds tracked by Wall St. Rank hold NOV as of Q4 2025.

  • Bayesian Capital Management reported no remaining NOV position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 21,100 NOV shares in Q4 2025, an estimated $280K.
  • Bayesian Capital Management first reported a position in NOV in Q3 2017 and held it in 11 quarters.
  • Bayesian Capital Management's NOV position peaked at $1.02M in Q1 2020.
  • 433 funds tracked by Wall St. Rank held NOV as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.